RecruitingNot ApplicableNCT06525181

AI as an Aid for Weekly Symptom Intake in Radiotherapy

Evaluation of AI-Enhanced Symptom Summarization in Weekly Radiotherapy Consultations: A Comparative Study


Sponsor

jaide

Enrollment

200 participants

Start Date

Jul 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study investigates the use of artificial intelligence (AI) and large language models (LLMs) to enhance the efficiency and accuracy of weekly treatment consultations (OTVs) in radiotherapy. It hypothesizes that an AI-enabled symptom summary tool will match traditional medical review methods in accuracy while saving time. The study includes patients undergoing pelvic radiotherapy and excludes those with pelvic reirradiation or who have undergone surgery. Patients will receive both standard and AI-assisted weekly consultations, with AI summaries generated using the OpenAI GPT-4 API. Blinded oncologists will compare the accuracy and quality of the AI-generated and doctor-generated summaries, while patients and doctors will rate these summaries. The primary objective is to evaluate the accuracy and time efficiency of AI-assisted symptom summaries compared to traditional methods.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All patients undergoing radiotherapy in the pelvic region.

Exclusion Criteria1

  • Cases of pelvic reirradiation or operated cases.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGenerative Artificial Intelligence

Gen AI assisted symptom intake summarization

OTHERStandard weekly symptom intake

Standard weekly symptom intake performed by a physician


Locations(1)

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA

Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06525181


Related Trials